Published in Clin Exp Immunol on January 01, 1976
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med (1988) 7.02
Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med (1980) 2.97
Leishmaniasis: current status of vaccine development. Clin Microbiol Rev (2001) 2.62
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect Immun (1983) 1.90
Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc Natl Acad Sci U S A (1985) 1.77
Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun (1993) 1.58
Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin Exp Immunol (1984) 1.40
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Infect Immun (1978) 1.25
Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability. Infect Immun (2003) 1.20
Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect Immun (2000) 1.19
Comparative study of American cutaneous leishmaniasis and diffuse cutaneous leishmaniasis in two strains of inbred mice. Infect Immun (1978) 1.17
Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology (1991) 1.14
Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect Immun (1986) 1.13
Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun (1997) 1.10
Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol (2001) 1.04
Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun (1994) 1.02
The site of Leishmania major infection determines disease severity and immune responses. Infect Immun (2003) 1.01
Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease. Clin Exp Immunol (1980) 1.01
Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. Infect Immun (1985) 0.93
Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect Immun (1987) 0.88
Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol (1987) 0.87
Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection. Infect Immun (1984) 0.86
Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing. Infect Immun (1985) 0.83
Intralesional plasma cells and serological responses in human cutaneous leishmaniasis. Clin Exp Immunol (1982) 0.83
Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice. Infect Immun (1988) 0.83
Nonspecific immunodepression and protective immunity in mice infected with Leishmania mexicana. Infect Immun (1981) 0.82
TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis. Immunology (1991) 0.81
Experimental models in vaccine research: malaria and leishmaniasis. Braz J Med Biol Res (2013) 0.79
Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity. Antimicrob Agents Chemother (2009) 0.79
Nitric oxide production by Peromyscus yucatanicus (Rodentia) infected with Leishmania (Leishmania) mexicana. Mem Inst Oswaldo Cruz (2013) 0.78
Eosinophils and mast cells in leishmaniasis. Immunol Res (2014) 0.77
Relationship between delayed hypersensitivity response and acquired cell-mediated immunity in C57BL/6J mice infected with Leishmania donovani. Infect Immun (1985) 0.75
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Cell-mediated and humoral immunity to protozoan infections. Transplant Rev (1974) 1.64
[Not Available]. Bull Soc Pathol Exot Filiales (1955) 1.01
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Immunological properties of the surface of parasitic nematodes. Nature (1979) 1.58
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Tissue damage in cattle infected with Theileria annulata accompanied by metastasis of cytokine-producing, schizont-infected mononuclear phagocytes. J Comp Pathol (1999) 1.29
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA (1973) 1.07
Ticks associated with wild mammals in Ghana. Bull Entomol Res (2005) 1.05
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05
Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res (1994) 1.05
Nitric oxide is produced by Cowdria ruminantium-infected bovine pulmonary endothelial cells in vitro and is stimulated by gamma interferon. Infect Immun (1998) 1.04
Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol (1982) 1.03
An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods (1987) 1.02
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol (1988) 1.00
Endothelial cell presentation of antigen to human T cells. Hum Immunol (1981) 0.99
Autoimmune mechanisms in inflammatory eye disease. Trans Ophthalmol Soc U K (1985) 0.99
Thymus and bursa dependence of lymphocyte mitogenic factor in the chicken. Nat New Biol (1972) 0.98
Cell-mediated cytotoxicity in Theileria annulata infection of cattle with evidence for BoLA restriction. Clin Exp Immunol (1983) 0.97
Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands. Ann Trop Med Parasitol (1969) 0.97
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Macrophages and protective immunity in Mycobacterium lepraemurium infections in a 'resistant' (C57Bl) and a 'susceptible' (BALB/c) mouse strain. Clin Exp Immunol (1982) 0.95
Numerical immunotaxonomy of Leishmania. I. Differentiation of four strains of Leishmania by serological tests. Immunology (1976) 0.94
Selective up-regulation of human granulocyte integrins and complement receptor 1 by cytokines. Immunology (1991) 0.94
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens. Graefes Arch Clin Exp Ophthalmol (1993) 0.92
Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes. Immunology (1992) 0.91
Rheumatoid blood decreases the adherence of polymorphonuclear cells (PMNs) to cultured endothelium. Ann Rheum Dis (1987) 0.91
Rheumatoid and normal synovial tissue in longterm culture. Evidence of cell heterogeneity and an approach to quantitation of of populations and the effect of passage. J Rheumatol (1978) 0.90
Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis. Clin Exp Immunol (1989) 0.90
Blood mononuclear cells from patients with psoriasis exhibit an enhanced adherence to cultured vascular endothelium. J Invest Dermatol (1991) 0.88
Passive administration of antibody against retinal S-antigen induces electroretinographic supernormality. Invest Ophthalmol Vis Sci (1992) 0.88
Immunogenicity of a ribosomal antigen of Leishmania enriettii. Trans R Soc Trop Med Hyg (1971) 0.88
The effects of antibodies on cells. 3. Studies on the interaction of rat liver mitochondria and lysosomes with antibody and complement. Immunology (1965) 0.88
The culture of vascular endothelial cells to confluence on microporous membranes. Thromb Res (1982) 0.88
The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol (2000) 0.88
Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines. Immunology (1977) 0.87
Accelerated cytodifferentiation of antibody-secreting cells in guinea-pig lymph nodes stimulated by sheep erythrocytes and lymphokines. Clin Exp Immunol (1975) 0.87
Mechanism(s) of attenuation of Theileria annulata vaccine cell lines. Trop Med Int Health (1999) 0.86
Reduction of the surface charge of blood polymorphonuclear cells by rheumatoid sera and heat induced aggregated human IgG (HAGG). Ann Rheum Dis (1988) 0.86
Serum from infected mice suppresses macrophage-mediated immunity in Mycobacterium lepraemurium infection: a model for imparied macrophage immunity in human leprosy. Trans R Soc Trop Med Hyg (1979) 0.86
Concanavalin A as an inducer of human lymphocyte mitogenic factor. Nat New Biol (1972) 0.86
Changes induced by local injection of human lymphoid cell lymphokine into dermal metastases of breast carcinoma: a light and electron microscopical study. J Pathol (1982) 0.85
The reaction of guinea-pigs to autologous and heterologous fibrin implants. J Pathol Bacteriol (1965) 0.85
Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha (TNF-alpha)-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expression. Clin Exp Immunol (1996) 0.85
Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compounds. Inflammation (1981) 0.85
Comparative biochemical analysis of purified S-antigen from human, bovine, porcine and rat retina. Exp Eye Res (1987) 0.85
Parvovirus associated antigen in the synovial membrane of patients with rheumatoid arthritis. Ann Rheum Dis (1987) 0.85
Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol (1994) 0.84
Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1997) 0.84
Adherence of rheumatoid polymorphonuclear cells (PMNs) to cultured endothelial cell monolayers. Ann Rheum Dis (1987) 0.83
Identification by cell electrophoresis of a subpopulation of polymorphonuclear cells which is increased in patients with rheumatoid arthritis and certain other rheumatological disorders. Ann Rheum Dis (1988) 0.83
Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane. Anesthesiology (1976) 0.83
Enhanced chemotaxis of monocytes in rheumatoid arthritis. Br J Rheumatol (1987) 0.82
Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF). Br J Haematol (1992) 0.82
Establishment of Theileria-infected bovine cell lines in scid mice. Parasite Immunol (1990) 0.82
Idiotypic expression of antibodies to retinal S-antigen in experimental autoimmune uveoretinitis. Immunology (1987) 0.81
Modulation of Fc and C3b receptor expression on guinea-pig macrophages by lymphokines. Clin Exp Immunol (1988) 0.81
Determination of lymphokine induced histamine release in vitro [proceedings]. Br J Pharmacol (1980) 0.81
Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules. Clin Exp Immunol (1997) 0.81
Experimental cellular allergic reactions in normal canine and malignant human prostate. Clin Exp Immunol (1976) 0.81
Nitric oxide inhibits establishment of macroschizont-infected cell lines and is produced by macrophages of calves undergoing bovine tropical theileriosis or East Coast fever. Parasite Immunol (1995) 0.81
Transendothelial chemotaxis in vitro of human monocytes. J Immunol Methods (1988) 0.80
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 2. Clinical relevance of antiretinal autoimmunity and circulating immune complexes. Br J Ophthalmol (1989) 0.80
[111In]oxine labelling of polymorphonuclear leucocytes: doubts concerning elution and effects on cell behaviour. Int J Nucl Med Biol (1985) 0.80
Modulation of experimental retinal vasculitis using dexamethasone, cyclosporin A, and prazosin. Eye (Lond) (1987) 0.80
Retinal vasculitis: correlation of animal and human disease. Eye (Lond) (1987) 0.80
Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (1996) 0.80